Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Halberd Corp HALB

Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents and four provisional patent applications related to the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:HALB)

Halberd & Athena GTX Report Initial Success of WatchDawg® PTSD Treatment Pilot Study

GlobeNewswire October 1, 2024

Halberd Partnership Secures Contract from Defense Atomics Corporation to Address Brain Injury and PTSD

GlobeNewswire September 11, 2024

Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg(TM) for Veteran Suicide Reduction

GlobeNewswire September 9, 2024

Halberd Corp. Issues Letter to Shareholders - Patented LDN+ Evolves into WatchDawg(TM) for Veteran Suicide Reduction

GlobeNewswire September 4, 2024

Halberd Corp. Issues Letter to Shareholders

GlobeNewswire August 26, 2024

Halberd Corp's (OTC: HALB) Groundbreaking Traumatic Brain Injury (TBI) Mitigation Nasal Spray Shows Promising Phase II Initial Test Results

GlobeNewswire July 24, 2024

Halberd/Athena GTX Research Promises a Much Brighter Future

Accesswire May 22, 2024

Halberd's Traumatic Brain Injury Treatment Projects Align with New U.S. House Bill

Accesswire May 9, 2024

Halberd's Patented LDN+ Drug Has Begun Pre-Pilot Trials With Military Veterans

Accesswire April 30, 2024
View More News ››

Opinion & Analysis (OTCPK:HALB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:HALB)

Halberd Corp. Issues Letter to Shareholders

JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to it...
AveragePenny - August 26, 2024

Halberd Corp’s (OTC: HALB) Groundbreaking Traumatic Brain...

JACKSON CENTER, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC-PINK: "HALB”) has announced encouraging...
AveragePenny - July 24, 2024

Halberd/Athena GTX Research Promises a Much Brighter Future

Walt Disney once said, "All our dreams can come true if we have the courage to pursue them". JACKSON CENTER, PA...
AveragePenny - May 22, 2024

Halberd's Traumatic Brain Injury Treatment Projects Align

Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously. ...
AveragePenny - May 9, 2024

Halberd's Patented LDN+ Drug Has Begun Pre-Pilot Trials With

News Link: https://www.accesswire.com/857948/halberds-patented-ldn-drug-has-begun-pre-pilot-trials-with-military-veterans JACKSON...
AveragePenny - April 30, 2024

Halberd's Patented Drug, LDN+, the Subject of a Limited ...

JACKSON CENTER, PA / ACCESSWIRE / April 4, 2024 / Halberd Corporation's (OTC PINK:HALB) Patented LDN+ Drug hits an...
AveragePenny - April 4, 2024
View more Bullboard ››

AJA Health and Wellness Inc.

AJA Health and Wellness Inc.

AJA Health and Wellness Inc. is focused on health and wellness solutions. The Company is engaged in operating a telemedicine ...
View More »